文献速递心力衰竭与心肌病

ATP依赖柠檬酸裂解酶缺失通过代谢重塑驱动左心室功能障碍

Loss of ATP-Dependent Citrate Lyase Drives Left Ventricular Dysfunction by Metabolic Remodeling.
PubMed 文献 · Circulation · 2026-07-20

研究利用非缺血性心肌病患者心脏组织及心肌细胞特异性Acly敲除小鼠,发现ACL丰度与活性降低导致乙酰辅酶A合成减少、能量流受损及AMP/ATP升高,进而引发左心室功能障碍;代谢应激激活AMPK与PKA磷酸化抑制YAP,而Idh1缺失可改善心功能并恢复YAP信号。

要点

  • 非缺血性心肌病患者心脏中ACL丰度与活性降低,与三羧酸循环中间产物减少相关。
  • 心肌特异性Acly敲除导致葡萄糖摄取与氧化增加、能量流受损、AMP/ATP升高及左心室功能障碍。
  • AAV9介导的心脏Idh1缺失可改善心功能与能量供应,减少YAP磷酸化并恢复下游信号。

核心结论

  • ACL通过调控脂质合成在心脏代谢与功能中起关键作用。
  • 利用柠檬酸代谢的代偿通路可能改善心力衰竭时的心脏功能。

研究设计与样本

  • 使用健康供体与非缺血性心肌病患者的人类心脏组织样本。
  • 采用CRISPR/Cas9基因编辑在Myh6-Cas9小鼠心肌细胞中失活Acly。
  • 使用体内正电子发射断层扫描与离体稳定同位素示踪标记量化Acly敲低后的代谢通量变化。
  • 进行RNA测序、基于质谱的代谢组学与蛋白质组学多组学分析,并整合至CardioNet代谢网络计算模型。

主要发现

  • 非缺血性心肌病患者心脏组织中ACL丰度与活性降低,与三羧酸循环中间产物丰度下降相关。
  • 心肌特异性ACL缺失减少乙酰辅酶A合成,导致葡萄糖摄取与氧化增加、能量流受损、AMP/ATP比值升高,共同促进左心室功能障碍。
  • 转录组学、代谢组学与蛋白质组学数据显示代偿性心脏脂质重塑及组蛋白3乙酰化降低。
  • 代谢应激激活AMPK与PKA,通过磷酸化介导YAP抑制。
  • 稳定同位素示踪与CardioNet模拟显示IDH1活性增加可防止胞质柠檬酸积累对糖酵解的变构抑制;AAV9介导心脏Idh1缺失改善心脏功能与能量供应,减少YAP磷酸化并恢复下游YAP信号。

临床怎么用

  • ACL及其下游代谢通路可能成为心力衰竭代谢干预的潜在靶点。
  • 靶向IDH1或柠檬酸代谢代偿通路可能改善心力衰竭时的心功能与能量供应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Metabolic adaptation and maladaptation are hallmarks of the failing heart and may be a target for therapeutic interventions. For example, sustained glucose oxidation during cardiac stress is associated with increased activity and abundance of ACL (ATP-dependent citrate lyase, Acly), which produces acetyl-coenzyme A (CoA) from citrate and CoA and supports de novo lipid synthesis. However, our understanding of how ACL supports cardiac metabolic adaptation and its potential to modulate disease pathophysiology has not yet been investigated. METHODS: We used human heart tissue samples from healthy donors and patients with nonischemic cardiomyopathy. Next, we used CRISPR (clustered, regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated 9) gene editing to inactivate Acly in cardiomyocytes of Myh6-Cas9 mice. In vivo positron emission tomography and ex vivo stable isotope tracer labeling were used to quantify metabolic flux changes in response to Acly knockdown. We conducted a multi-omics analysis using RNA sequencing and mass spectrometry-based metabolomics and proteomics. Experimental data were integrated into computational modeling using the metabolic network CardioNet to identify significantly dysregulated metabolic processes at a systems level. RESULTS: We observed reduced ACL abundance and activity in human heart tissue samples from patients with nonischemic cardiomyopathy, which correlated with decreased abundance of Krebs cycle intermediates. Using CRISPR/Cas9 gene editing, we found that cardiac-specific loss of ACL reduces acetyl-CoA synthesis, leading to altered cardiac metabolism characterized by increased glucose uptake and oxidation, impaired energy flux, and elevated AMP to ATP ratios, which collectively promote left ventricular dysfunction. Transcriptomic and mass spectrometry-based metabolomics, as well as proteomic data, reveal compensatory cardiac lipid remodeling and reduced histone 3 acetylation. This metabolic stress promotes activation of AMPK (AMP kinase) and PKA (protein kinase A), which in turn mediates YAP (Yes-associated protein) inhibition through phosphorylation. Stable isotope tracer studies combined with CardioNet simulations demonstrated that increased IDH1 (isocitrate dehydrogenase 1) activity prevents allosteric inhibition of glycolysis from cytosolic citrate accumulation. AAV9-mediated cardiac Idh1 deletion improved cardiac function and energy provision, reducing YAP phosphorylation and restoring downstream YAP signaling. CONCLUSIONS: Our findings suggest that ACL plays a pivotal role in cardiac metabolism through regulating lipid synthesis and cardiac function. Exploiting compensatory pathways of citrate metabolism may improve cardiac function during heart failure.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Liu S, Gammon ST, Tan L, et al. Loss of ATP-Dependent Citrate Lyase Drives Left Ventricular Dysfunction by Metabolic Remodeling. Circulation. 2026. PMID: 42475434. doi:10.1161/CIRCULATIONAHA.125.076453

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。